Daily BriefsEvent-Driven

Daily Brief Event-Driven: ESR Group (1821 HK): Inching Closer to a Binding Proposal and more

In today’s briefing:

  • ESR Group (1821 HK): Inching Closer to a Binding Proposal
  • 7&I (3382) – Asset Sale News Designed to Get Shareholder Attention to Future Value
  • WisdomTree Emerging Markets High Dividend Index Rebalance: US$2.5bn Round-Trip Trade
  • WisdomTree Emerging Markets SmallCap Dividend Index Rebalance: US$1bn to Trade
  • Korea Zinc: Breaking Down the Cancel Risk with Specific Legal Provisions for Both Camps
  • CPMC Holdings (906.HK) Privatization Update – Will ORG Withdraw Midway?
  • Merger Arb Mondays (07 Oct) – GA Pack, Henlius, Canvest, Samson, T-Gaia, Descente, Platinum
  • EQD | Asia Monthly Vol Roadmap: Elevated IV’s in CSI300 and Hang Seng Present Tactical Opportunity
  • EQD / NSE Vol Update / Skew & Smile Unmoved by Equity Selloff – Options Market Ill-Prepared for More
  • Temasek’s USD1Bn+ Bite into India’s Booming Snack Food Sector.Top Listed Stocks to Watch


ESR Group (1821 HK): Inching Closer to a Binding Proposal

By Arun George

  • ESR Group (1821 HK) provided a positive update on the indicative proposal. The update notes that the consortium has expanded from three to six, representing 39.91% of outstanding shares.
  • The addition of new consortium members is a positive. While the recent market rally is not a dealbreaker, it should give the consortium renewed impetus to launch an acceptable offer.   
  • The downside to a deal break is low as ESR’s valuation is undemanding, which is supported by the potential earnings recovery in a more benign interest rate environment.

7&I (3382) – Asset Sale News Designed to Get Shareholder Attention to Future Value

By Travis Lundy

  • Seven & I Holdings (3382 JP) is currently “in limbo” as the initial Alimentation Couche-Tard (ATD CN) (“ACT”) has been rejected, some news is out, and we await earnings/presentations.
  • The news last week was that 7&i might sell down a stake in Seven Bank Ltd (8410 JP) and could sell its retail/superstore business to PE rather than an IPO.
  • Both selldowns mean the focus on CVS everyone seems to want. That’s good news. And the shares are trading at/below ACT terms which “grossly undervalued” the company. Bullish. 

WisdomTree Emerging Markets High Dividend Index Rebalance: US$2.5bn Round-Trip Trade

By Brian Freitas

  • The WisdomTree Emerging Markets High Dividend Index is a fundamentally weighted index that measures the performance of high dividend yield stocks within emerging markets.
  • The changes at the October rebalance were announced after market close on 4 October with implementation scheduled at the close on 16 October.
  • There are 241 adds and 208 deletes for the index with an estimated round-trip trade of US$2.5bn. There are many stocks with over 2x ADV to trade.

WisdomTree Emerging Markets SmallCap Dividend Index Rebalance: US$1bn to Trade

By Brian Freitas

  • The WisdomTree Emerging Markets SmallCap Dividend Index is a fundamentally weighted index that measures the performance of small cap stocks within Emerging Markets.
  • The changes at the October rebalance were announced after market close on 4 October with implementation scheduled at the close on 16 October.
  • There are 8 trading days to implementation and there are a bunch of stocks with over 2x ADV to trade.

Korea Zinc: Breaking Down the Cancel Risk with Specific Legal Provisions for Both Camps

By Sanghyun Park

  • MBK is unlikely to lower the tender price or cancel the offer due to legal constraints and potential regulatory hurdles, along with compensating investors.
  • Just keep in mind that if you want to participate in MBK’s Korea Zinc offer, you’ll need to submit your bid to secure that compensation safety net.
  • We can’t rule out the second injunction request being accepted on the 21st, leaving Choi’s camp in a tough position with tender offer cancellation risks compared to MBK.

CPMC Holdings (906.HK) Privatization Update – Will ORG Withdraw Midway?

By Xinyao (Criss) Wang

  • Acquiring CPMC at low price is in line with Baosteel’s strategic goals and the new assessment indicators of Baowu Group. This explains why Baosteel didn’t choose to raise its Offer 
  • ORG intends to acquire 100% equity of CPMC. This means state-owned capital needs to withdraw completely from CPMC. So, would China Foods/COFCO (both SOEs) agree to be acquired by ORG?
  • If ORG is “forced to” acquire CPMC due to Baosteel’s low Offer Price, will ORG change mind and choose to withdraw midway?Such “potential unwillingness” from ORG makes the deal “tricky”.


EQD | Asia Monthly Vol Roadmap: Elevated IV’s in CSI300 and Hang Seng Present Tactical Opportunity

By John Ley


EQD / NSE Vol Update / Skew & Smile Unmoved by Equity Selloff – Options Market Ill-Prepared for More

By Sankalp Singh

  • Nifty50 Monthly IVs post +2.6 vol jump as risk premia gets marked higher on return from 02.10.2024 holiday – China-induced Index selloff & FII Options-buying being the main drivers.
  • Vol Term-Structure has switched from Contango to Backwardation in the front end for Nifty50 options. BankNifty Vol Curve flattens due to 11th hour IV markdown. 
  • Options Market looks ill-prepared for another leg lower in indices – Smile & Skew subdued in spite of IV-jump.

Temasek’s USD1Bn+ Bite into India’s Booming Snack Food Sector.Top Listed Stocks to Watch

By Devi Subhakesan

  • Temasek Holdings Pte Ltd (TMSK SP), Singapore’s state investment firm, is reportedly eyeing a 10-15% stake in India’s top snack maker Haldirams (Unlisted), valued at $11 billion.
  • India’s packaged and processed food sector is booming, driven by modern retail growth, improved food standards, rising convenience demand, and greater affordability.
  • Big acquisitions, upcoming IPOs, and strong growth prospects keep this sector in the spotlight, with listed companies offering investors opportunity to play the upswing.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars